ST. LOUIS, January 11, 2024 – Solis Agrosciences, created to provide R&D crop development services, today announced the appointments of Charlie Bolten as Chief Executive Officer and Susan Martino-Catt, PhD, as Chief Operating Officer.

“Solis is off to a fantastic start, and we are excited to have the opportunity to bring such strong management talent into the company,” said Solis Co-founder and Board Chair Martha Schlicher, PhD. “I’ve worked closely with Charlie and Susan for years and know that they are the right leaders to help accelerate the Solis vision.”

Prior to joining Solis, Bolten was President of BioGenerator Ventures, where he led the organization, which focuses on building Agtech businesses among other startups. While at BioGenerator, Bolten co-founded Solis and served on its board of directors. He previously served as Board Chair of CoverCress, which was acquired through a joint venture between Bayer, Chevron and Bunge.  Bolten also served on the boards of directors for Impetus Agriculture, MediBeacon, Plastomics, SentiAR, Canopy Biosciences (acquired by Bruker), Confluence Life Sciences (acquired by Aclaris) and numerous other startup companies. Before joining BioGenerator Ventures, Bolten worked as a research scientist at Monsanto, Searle, Pharmacia and Pfizer.

“I am thrilled to join the Solis team,” said Bolten. “St. Louis is a global leader in Agtech research, and Solis, with its impressive portfolio of client companies from around the world, is strongly positioned to help continue building momentum in the 39 North Agtech Innovation District and to become a premier enabler for Agtech innovators.” READ MORE